Pivotal bioVenture Partners Fund I, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Oculis Holding AG Ordinary Shares, CHF 0.01 par value per share (OCS)

Filing Manager
Pivotal bioVenture Partners Fund I, L.P.
Reporting Manager
Nan Fung Group Holdings Limited
Security
Oculis Holding AG Ordinary Shares, CHF 0.01 par value per share
Symbol
OCS
Shares outstanding
57.5M shares
Disclosed Ownership
2.82M shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:30:04
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nan Fung Group Holdings Limited 4.9% 2.82M 0 2.82M /s/ Tang Chun Wai Nelson Tang Chun Wai Nelson, Director
NF Investment Holdings Limited 4.9% 2.82M 0 2.82M /s/ Tang Chun Wai Nelson Tang Chun Wai Nelson, Director
Nan Fung Life Sciences Holdings Limited 4.9% 2.82M 0 2.82M /s/ Sun Xintong Sun Xintong, Director
NFLS Platform Holdings Limited 0.9% 515K 0 515K /s/ Sun Xintong Sun Xintong, Director
NFLS Beta Limited 0.9% 515K 0 515K /s/ Sun Xintong Sun Xintong, Director
Pivotal Life Sciences Holdings Limited 4% 2.3M 0 2.3M /s/ Sun Xintong Sun Xintong, Director
Pivotal Partners Ltd 4% 2.3M 0 2.3M /s/ Sun Xintong Sun Xintong, Director
Pivotal bioVenture Partners Fund I U.G.P. Ltd. 4% 2.3M 0 2.3M /s/ Robert Hopfner Robert Hopfner, Authorized Signatory
Pivotal bioVenture Partners Fund I G.P., L.P. 4% 2.3M 0 2.3M /s/ Robert Hopfner By: Pivotal bioVenture Partners Fund I U.G.P. Ltd., its general partner; By: Robert Hopfner, Authorized Signatory
Pivotal bioVenture Partners Fund I, L.P. 4% 2.3M 0 2.3M Pivotal bioVenture Partners Fund I G.P., L.P. its general partner